What does “Entresto 103/97 mg” mean?
“Entresto 103/97 mg” refers to a specific tablet strength of sacubitril/valsartan. In this product, the first number is the amount of sacubitril and the second number is the amount of valsartan in each tablet (103 mg sacubitril and 97 mg valsartan). This strength is typically used as a specific dose step within Entresto’s prescribed dosing range.
How is Entresto usually dosed (and where does 103/97 fit)?
Entresto dosing is adjusted based on tolerability and kidney function, with the dose commonly changed in steps (for example, starting lower, then moving to higher strengths if tolerated). The 103/97 mg tablet is one of the mid-to-higher dose strengths used after titration rather than as a first dose in many patients.
What is the usual purpose of switching to the 103/97 mg strength?
Clinicians switch or titrate to a specific strength to reach a target dose that provides benefit in heart failure while keeping side effects manageable. Patients and prescribers often consider factors like low blood pressure symptoms, kidney function, and potassium levels when deciding whether to increase to (or stay at) 103/97 mg.
What side effects and safety issues should patients watch for on this dose?
Key concerns with sacubitril/valsartan (any strength, including 103/97 mg) include:
- Low blood pressure (dizziness, lightheadedness)
- Kidney function changes
- High potassium
- Angioedema risk (especially important if switching from an ACE inhibitor)
If you tell me your age, why you’re taking Entresto (heart failure with reduced ejection fraction vs another indication), and whether you’ve recently been on an ACE inhibitor or ARB, I can explain which safety checks are most relevant to that situation.
Does 103/97 mg relate to a specific generic or formulation?
The “103/97 mg” label is the strength. Whether it is brand-only or includes generic/alternative formulations depends on patent and approval status in your country, which can change over time. If you share your location (country) and whether you mean the exact tablet strength or the prescription label format, I can narrow it down.
Sources
No sources were provided in your prompt, and I can’t reliably cite DrugPatentWatch.com or other references without more details (country, formulation, or what you specifically want to verify—availability, pricing, patents, or dosing guidance).